All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Silo Pharma (SILO) Stock Tumbles 28% Following $4M Financing Announcement

Silo Pharma (SILO) stock dropped 28% to $5.57 after announcing a $4M private placement with warrants that could generate an additional $7.7M upon exercise. The post Silo Pharma (SILO) Stock Tumbles…

Read the full article
1d ago

You might also wanna read

Silo Pharma prices $11.7M at-the-market offering at $6.45 per share

See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F

thefly.com·1d ago

Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know.

This big pharma stock looks attractive for income investors -- but it comes with some risk.

Bars·5d ago

Oklo (NYSE: OKLO) Stock Price Tumbles 22% In June As DOE Loan Program Rattles SMR Investors

Oklo (NYSE: OKLO) shares dropped 21.8% in June, according to data from S&P Global Market Intelligence, even as the company racked up a strin

Foreign Policy Journal·4d ago

SpaceX stock drops 23% from peak, falls below IPO price after 16% plunge

Shares of Elon Musk’s SpaceX tech conglomerate plunged 16% Monday to close below their price on June 12, after the company’s massive initial

nbcnews.com·19d ago

SpaceX stock drops 23% from peak, falls below IPO price after 16% plunge

Shares of Elon Musk’s SpaceX tech conglomerate plunged 16% Monday to close below their price on June 12, after the company’s massive initial

nbcnews.com·19d ago

SpaceX stock drops 23% from peak, falls below IPO price after 16% plunge

Shares of Elon Musk’s SpaceX tech conglomerate plunged 16% Monday to close below their price on June 12, after the company’s massive initial

nbcnews.com·19d ago

AstraZeneca Stock Tumbles 6% Following Late-Stage Heart Disease Drug Trial Failure

AstraZeneca stock fell 9% after its Wainua heart drug trial missed its primary goal, raising questions about management credibility.

TIKR·1d ago

Cue Biopharma to sell 1.418M shares at $33.21 in private placement

See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F

thefly.com·1d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.